Clinical Trials Browser

INDUSTRY × Graft vs Host Disease × Prednisone × Clear all

NCT00136903 2022-01-31

Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Lymphoma

NCT02953678 2021-11-24

A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)

Phase 2 Completed

71 enrolled 24 charts 1 FDA

Graft vs Host Disease